Table 2.
H2-receptor antagonists
|
Proton pump inhibitors
|
|||
---|---|---|---|---|
Treatment-naive patients | Treatment-experienced patients | Treatment-naive patients | Treatment-experienced patients | |
Without tenofovir | Do not exceed dose equivalent of famotidine 40 mg twice daily‡ | Do not exceed dose equivalent of famotidine 20 mg twice daily‡ | Do not exceed dose equivalent of omeprazole 20 mg once daily§ Consider an increase to atazanavir/r 400/100 mg once daily | Co-administration should be avoided |
| ||||
With tenofovir | Do not exceed dose equivalent of famotidine 40 mg twice daily‡ | Do not exceed dose equivalent of famotidine 20 mg twice daily‡ Increase atazanavir/r to 400/100 mg once daily | Do not exceed dose equivalent of omeprazole 20 mg once daily§ Consider an increase to atazanavir/r 400/100 mg once daily | Co-administration should be avoided |
Except where noted, atazanavir should be given as 300 mg with ritonavir 100 mg once daily.
Atazanavir/r should be administered simultaneously with or at least 10 h after the H2-receptor antagonist.
Omeprazole should be administered approximately 12 h prior to atazanavir/r.
Atazanavir/r: Atazanavir/ritonavir.